Navigation Links
Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™
Date:7/19/2011

cision support for almost a decade.  With eviti, not only are oncologists empowered to make more informed treatment decisions, but payers have instant visibility into treatment details before the treatment begins.  Treatment Pathway Connections, supported by eviti, will allow Medco to offer its suite of oncology services at the optimal time in the care process, at the point of treatment prescription, ensuring that patients receive the right treatment at the right place with the right support.

"Medco's decision to utilize our independent, unbiased decision-support platform – eviti – to extend the value of its oncology offering is testament to the growing need for a holistic approach to improving care and outcomes.  eviti will be at the forefront of the treatment selection process addressing the clinical complexities and financial challenges of an evolving cancer landscape," said Eduardo Beruff, president and chief executive officer for ITA Partners | eviti.

Cancer Game Changers

The science is advancing rapidly and Medco has been among the first to incorporate innovations such as genetic testing on a widespread scale when certain drugs are prescribed.  Cancer drugs have been among the most prominent medications with companion diagnostic testing and ties to pharmacogenomics.  Medco has a personalized medicine program related to tamoxifen, as well as a program for BCR-ABL testing in patients with chronic myeloid leukemia using imatinib (Gleevec®), dasatinib (Sprycel®) or nilotinib (Tasigna®).  Testing of tumor tissue itself for a specific genomic signature or biomarkers is necessary to confirm that several other new and investigational cancer drugs are used appropriately.  DNA Direct®, a Medco subsidiary, has genetic counselors who advise physicians, patients, and payers about the best approaches for using genetic testing and molecular diagnostics.  When Treatment
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... YORK , May 21, 2013 /PRNewswire/ ... research report is available in its catalogue: ... Regulatory and Reimbursement Scenario for Medical Devices ... http://www.reportlinker.com/p01188015/Changing-Regulatory-and-Reimbursement-Scenario-for-Medical-Devices-in-the-US-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging   Changing ... in the US Market   ...
(Date:5/21/2013)... MONROVIA, Calif. , May 21, 2013 ... leading developer, manufacturer and marketer of minimally invasive ophthalmic ... upcoming investor conferences to review the Company,s recent financial ... STAAR Surgical will present at the 38 ... Boston at the Westin Waterfront ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4STAAR Surgical To Present At Upcoming Investor Conferences 2
... Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today ... that once-daily Victoza ® in combination with metformin produced sustained and significantly ... ® plus metformin at 52 weeks. , ... Key findings from the study include: , ...
... JACKSONVILLE, Fla. , June 28 ... of its SurgiSteer™ laparoscopic instruments.  Developed from licensed ... will exploit single port laparoscopic surgery with its ... and Endo Scissors, available in both free and ...
Cached Medicine Technology:New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 2New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 3New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 4New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 5New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 6New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 7Steerable Technologix LLC Announces Release of SurgiSteer Laparoscopic Instruments 2
(Date:5/21/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) ... drowsy run a higher risk of getting into car ... up on missed sleep on weekends puts them in ... "This is another challenge to adolescents that comes ... director and founder of the Center for Injury Research ...
(Date:5/21/2013)... of non-small cell lung cancer (NSCLC) in U.S. hospitals ... according to a new study., "In most patients, the ... is surgery," said researcher Jayanth Adusumalli, MBBS, of the ... study of more than 1,200,000 patients diagnosed with NSCLC ... we found statistically significant racial disparities in the surgical ...
(Date:5/21/2013)... an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring ... protects the lung,s elasticity, is effective in slowing ... antitrypsin deficiency (AATD), a life-threatening genetic disorder, according ... American Thoracic Society International Conference. , The study ... of lung tissue as measured by computed tomography ...
(Date:5/21/2013)... 2013 According to the Los ... to make possession of controlled substances (heroin, cocaine, crystal ... offense. MacGregor & Collins Orange County criminal lawyers believe ... overcrowding as well as improving rehabilitation rates amongst controlled ... bill met a great deal of resistance from the ...
(Date:5/21/2013)... 21, 2013 The first ever over-the-counter ... Seal, Anti Itchbalm, is ready to come to pharmacies ... and effective product which will help attract more customers ... community. , US Organic Group Corp. has developed Anti ... can be safely used on both adults and children, ...
Breaking Medicine News(10 mins):Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 2Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 3Health News:New Drug Bill to Lower Penalties for Possession of Controlled Substances Gains Support from Criminal Lawyers 2Health News:First Ever Over-the-Counter Organic Anti-Itch Ointment Developed by US Organic Group Corp. 2
... that craving a cigarette while performing a cognitive task ... wandering, but also makes that person less likely to ... The paper, titled "Out for a Smoke: The Impact ... the first evidence that craving disrupts an individual,s meta-awareness, ...
... , INDIANAPOLIS, Dec. 7 ... the availability of a smaller insulin vial, the first in the ... with diabetes being treated in a hospital. , The new smaller ... origin]) and Humulin® R-U100 (regular insulin human injection, ...
... , HORSHAM, Pa., Dec. 7 ... TEVA ), today announced the publication of four articles ... Journal of Allergy and Clinical Immunology (JACI), providing ... small airways in the understanding and treatment of asthma. This ...
... new University of Pittsburgh study reveals that craving a ... the chances of a person,s mind wandering, but also ... or her mind has wandered. The paper, titled ... on Zoning Out During Reading," provides the first evidence ...
... ... Hunt, a range of experts and healthcare leaders will focus on sharing best practices ... industries will discuss lessons learned in developing functional health information exchanges which provide safer ... ...
... who have been infected with West Nile virus may ... initial infection, potentially leading to kidney problems. The research, ... Journal of Infectious Diseases , is now available ... West Nile virus was first detected in the United ...
Cached Medicine News:Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:West Nile virus infection may persist in kidneys years after initial infection 2Health News:West Nile virus infection may persist in kidneys years after initial infection 3
... is a state-of-the-art hair reduction and ... specially designed for use within a ... features and economy in a single ... treatment of unwanted hair, photo rejuvenation ...
... perfect mix of powerful, versatile, and innovative ... Palomar StarLux® Pulsed Light and Laser System.,With ... compact base unit so theres no ... treatments., You can choose among Laser, Intense ...
Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
Medicine Products: